OQROGet OQRO Pro
Insider trade

Janux Therapeutics (JANX)10% owner sold ~$1.49M

Avalon Ventures XI, 10% owner at Janux Therapeutics, sold ~$1.49M of Janux Therapeutics shares.

~$1.49M
Approx. value · 29K sh @ $50.61
2.73M
Holds after · shares reported
Traded
Oct 16, 2024
Filed
Oct 18, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 13, 2024Insider10% owner sold ~$178K of JANX shares in the open market
  2. Oct 16, 2024 · this disclosureInsider10% owner sold ~$1.49M of JANX shares in the open market

What came next

  1. Oct 16, 2024Insider · 1 personInsiders: 6 sales (~$9.0M)
  2. Oct 17, 2024Insider10% owner sold ~$92K of JANX shares in the open market
  3. Oct 18, 2024Insider · 2 peopleInsiders: 1 purchase (~$53.7M), 9 sales (~$66.9M)
  4. Oct 28, 2024Insider · 1 personInsiders: 2 sales (~$1.3M)
  5. Nov 25, 2024Insider · 1 personInsiders: 2 sales (~$1.3M)
  6. Dec 3, 2024InsiderCEO sold ~$1M of JANX shares in the open market
  7. Dec 24, 2024InsiderCEO sold ~$1.4M of JANX shares in the open market
  8. Jan 2, 2025Insider · 1 personInsiders: 5 sales (~$732K)
  9. Jan 7, 2025InsiderCEO sold ~$300K of JANX shares in the open market
  10. Feb 3, 2025Insider · 1 personInsiders: 3 sales (~$141K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Janux Therapeutics

For Janux Therapeutics, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JANX page.

Other recent filings by Avalon Ventures XI, L.P., 10% owner

The full history of Avalon Ventures XI, L.P., 10% owner is on the profile page.

How this filing works

Other disclosures at Janux Therapeutics

Everything OQRO holds on this company is on its JANX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data